← Browse by Condition
Medical Condition

renal replacement therapy

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for renal replacement therapy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — renal replacement therapy Clinical Trials

How many clinical trials are currently recruiting for renal replacement therapy?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for renal replacement therapy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for renal replacement therapy?
renal replacement therapy research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a renal replacement therapy clinical trial?
Eligibility criteria for renal replacement therapy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
University of Thessaly 1 trial
Cleveland Clinic Abu Dhabi 1 trial
University Hospital, Montpellier 1 trial

Recruiting Clinical Trials

NCT06226441
Recruiting

Aminoglycoside Administration in Septic Patients

Enrollment
50 pts
Location
Greece
Sponsor
University of Thessaly
View Trial →
NCT03636464
Recruiting

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies

Enrollment
200 pts
Location
United Arab Emirates
Sponsor
Cleveland Clinic Abu Dhabi
View Trial →
NCT03329313 Phase 2
Recruiting

Effects of Variation of Sodium Dialysate in ICU

Enrollment
158 pts
Location
France
Sponsor
University Hospital, Montpelli...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology